Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk

This publication has 10 references indexed in Scilit:

• Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
  The Lancet, 2003
• Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels
  The American Journal of Cardiology, 2001
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Lipids and vascular disease: what we do and do not know
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1999
• Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular Study
  Circulation, 1996
• Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Que´bec cardiovascular study)
  The American Journal of Cardiology, 1995
• Comparative Effects of Lovastatin and Niacin in Primary Hypercholesterolemia
  Archives of internal medicine (1960), 1994
• Does measurement of apolipoprotein B have a place in cholesterol management?
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• The Measurement of Observer Agreement for Categorical Data
  Published by JSTOR ,1977
• Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
  Clinical Chemistry, 1972